Expression production for recombination immunoglobulin capable of specifically identifying blood vessel endothelial cell growth factor and application thereof

The invention relates to a treatment of depressing vascular endothelial growth factor, VEGE and the antineoplastic vascular proliferation of receptor thereof developing into an essential way to cure tumor at present. The invention chooses the vascular endothelial growth factor and the receptor there...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	HU HONGQUN, ZHOU QUNMIN, TAO FEILONG, MA LINGSHA, XU YIQING
Format:	Patent
Sprache:	chi ; eng
Schlagworte:	BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS THEREOF CULTURE MEDIA ENZYMOLOGY HUMAN NECESSITIES HYGIENE INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES MEASURING MEDICAL OR VETERINARY SCIENCE METALLURGY MICROBIOLOGY MICROORGANISMS OR ENZYMES MUTATION OR GENETIC ENGINEERING ORGANIC CHEMISTRY PEPTIDES PHYSICS PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS SPIRITS TESTING VINEGAR WINE
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The invention relates to a treatment of depressing vascular endothelial growth factor, VEGE and the antineoplastic vascular proliferation of receptor thereof developing into an essential way to cure tumor at present. The invention chooses the vascular endothelial growth factor and the receptor thereof as targets, and a great deal of expression in vitro of genetic engineering and cell engineering are used to produce a recombine immunoglobin that can specifically identify and combine humanization of endothelial growth factor in human vein. The recombinant immunoglobin is a potential tumor treatment medicine for antagonizing vascular proliferation.